Please login to the form below

FujiFilm

This page shows the latest FujiFilm news and features for those working in and with pharma, biotech and healthcare.

Novavax also partnered with FUJIFILM Diosynth Biotechnologies to manufacture certain components of the vaccine in the UK.

Novavax moves closer toward launch of US phase 3 COVID-19 vaccine trial

study. Novavax is planning to use vaccine material produced at a FUJIFILM Diosynth Biotechnologies plant in North Carolina to support the commercial scale-up required for phase 3 trials in the
Novavax starts first phase 3 COVID-19 vaccine trial in the UK

The UK government also signed a deal with Novavax in August, which led to the phase 3 clinical trial, and has also partnered with FUJIFILM Diosynth Biotechnologies to manufacture certain components
UK agrees on COVID-19 vaccine deals with J&J and Novavax

Novavax will also conduct a phase 3 clinical trial of its vaccine candidate with support from the UK’s National Institute for Health Research (NIHR), and has partnered with FUJIFILM Diosynth
Bayer takes control of BlueRock stem cell joint venture

The venture unit followed that a few weeks later with a $215m investment in Century Therapeutics, with additional backing for the company coming from Versant and Fujifilm Cellular Dynamics.
Pfizer closes on EU approval of lung cancer drug Vizimpro

The two new biosimilars will join products from Amgen, Samsung Bioepis/Biogen, Mylan/Fujifilm Kyowa Kirin, and Novartis’ Sandoz unit in an assault on AbbVie’s market share for the

More from news
Approximately 2 fully matching, plus 10 partially matching documents found.

Deal Watch March 2016

The sale of the diagnostic imaging business was believed to be hotly contested by Fujifilm and Konica Minolta, with Canon the successful bidder.
Pharma deals in July 2015

Still in Japan, a week later AZ agreed a joint venture with Fujifilm Kyowa Kirin Biologics for the development and commercialisation of a biosimilar version of bevacizumab (Avastin) in phase I ... Fujifilm Kyowa KirinBiologics will transfer the product
Pharma deals in March 2015

The high level of interest in cell therapies generally may have been one reason why Fujifilm acquired Cellular Dynamics for $307m at an eye watering share price premium of 108%. ... Fujifilm expects to achieve significant synergies. Checkpoint inhibitors

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

BIA elects six new board members

The remaining new appointments are Stephen Taylor of Fujifilm Diosynth Biotechnologies; Donna Hackett, director of life sciences consultancy firm KDH BioManagement; and Tim Watts, chief financial officer of Oxford BioMedica.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Home Working Medical Copy Writer & Senior Medical Copy Write...: Highly Competitive Salary, Bonus &Benefits

Client Services Director – London or Home Based – Medical Commun...: Highly Competitive Salary, Bonus &Benefits

Freelance Medical Writer - Creative Healthcare Comms - 2 month t...: Excellent Day Rate

Editor & Senior Editor - Medical Communications - Home Based: Highly Competitive Salary, Bonus &Benefits

FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...: Highly Competitive Day Rate, Bonus &Benefits

Senior Account Director & Associate Director - Healthcare Ad...: Highly Competitive Salary, Bonus &Benefits

Freelance Account Manager - Creative Healthcare Comms - Immediat...: Excellent Day Rate

Senior Account / Programme Manager - MedComms - Buckinghamshire: Highly Competitive Remuneration packages

Senior Leadership Role – Medical Communications – North West: Highly Competitive Salary, Bonus &Benefits

Medical Writer, Senior Medical Writer, Principal Medical Writer,...: Highly Competitive Salary, Bonus &Benefits

Add my company

The biggest problems facing humanity today are health-related, and the health of people, animals and our planet are inextricably linked. ...

InSite Events™ National Pharma Meeting: A Customer Story: How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?: The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19: The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...